Profound Medical Corp. Cost of Revenue 2011-2026 | PROF

Cost of Revenue is a financial metric that reflects all direct costs associated with the production of goods or the provision of services that directly led to revenue during the reporting period. It is the total amount of expenses incurred by the company to deliver its products or services, including both production costs and related expenses necessary for delivery or customer support.

What is included in the cost of revenue

Cost Category	Examples
Production Costs	Materials, wages of production staff, depreciation of equipment
Service and Support	Customer service, user support, technical assistance
Delivery and Logistics	Packaging, delivery of goods to customers
Hosting and Infrastructure	Servers, cloud platforms (especially for IT and SaaS companies)
Content and Licenses	License purchases, production royalties (e.g., in streaming services)

Importance of the Metric

Helps to understand how costly the revenue-generating process is.
A high cost of revenue may indicate:
Poor cost control
Low operational efficiency
A low cost of revenue combined with high revenue indicates high profitability and business competitiveness.

Annual Cost of Revenue Profound Medical Corp.

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	3.92 M	3.83 M	1.78 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
3.92 M	1.78 M	3.18 M

Cost of Revenue of other stocks in the Medical devices industry

Issuer	Cost of Revenue	Price	% 24h	Market Cap	Country
Inogen INGN	194 M	$ 6.32	-2.02 %	$ 168 M	USA
IRadimed Corporation IRMD	19.5 M	$ 99.89	0.69 %	$ 1.27 B	USA
Axonics Modulation Technologies AXNX	76 M	-	-	$ 3.31 B	USA
Aziyo Biologics AZYO	5.7 M	-	1.37 %	$ 20.5 M	USA
Acutus Medical AFIB	10.3 M	-	-26.83 %	$ 2.62 M	USA
Allied Healthcare Products AHPI	24.5 M	-	3.58 %	$ 2.21 M	USA
BioSig Technologies BSGM	57 K	-	37.08 %	$ 85.7 M	USA
Conformis CFMS	38.8 M	-	-	$ 16.4 M	USA
Cardiovascular Systems CSII	63.4 M	-	0.15 %	$ 844 M	USA
IRIDEX Corporation IRIX	30.1 M	$ 1.35	-0.04 %	$ 21.8 M	USA
Apollo Endosurgery APEN	34.4 M	-	-	$ 475 M	USA
LivaNova PLC LIVN	448 M	$ 63.27	0.05 %	$ 3.45 B	Britain
LENSAR LNSR	27.6 M	$ 5.71	-5.93 %	$ 65.8 M	USA
Avinger AVGR	5.65 M	-	-20.74 %	$ 369 K	USA
AxoGen AXGN	57.9 M	$ 32.42	2.11 %	$ 1.49 B	USA
CONMED Corporation CNMD	624 M	$ 36.72	0.25 %	$ 1.14 B	USA
Medtronic PLC MDT	11.6 B	$ 86.65	-0.64 %	$ 111 B	USA
Electromed ELMD	14 M	$ 24.67	0.73 %	$ 209 M	USA
Neovasc NVCN	556 K	-	-	$ 111 M	Canada
Cytosorbents Corporation CTSO	10.5 M	$ 0.72	6.7 %	$ 39.2 M	USA
Aethlon Medical AEMD	3.87 M	$ 2.15	-6.52 %	$ 3.36 M	USA
BIOLASE BIOL	32.4 M	-	-13.19 %	$ 166 K	USA
Orthofix Medical OFIX	256 M	$ 11.77	-0.84 %	$ 466 M	Curacao
AdaptHealth Corp. AHCO	2.64 B	$ 11.48	10.66 %	$ 1.55 B	USA
Myomo MYO	14 M	$ 0.69	-2.17 %	$ 28.9 M	USA
Nano-X Imaging Ltd. NNOX	21.9 M	$ 2.33	-4.71 %	$ 137 M	Israel
Invacare Corporation IVC	566 M	-	-	$ 24.7 M	USA
EDAP TMS S.A. EDAP	37.6 M	$ 3.85	3.08 %	$ 144 M	France
OrthoPediatrics Corp. KIDS	63.7 M	$ 15.84	-3.83 %	$ 372 M	USA
Penumbra PEN	461 M	$ 334.58	-0.3 %	$ 13 B	USA
Outset Medical OM	72.7 M	$ 3.49	-3.6 %	$ 53.1 K	USA
Inspire Medical Systems INSP	133 M	$ 51.53	-1.3 %	$ 1.51 B	USA
Insulet Corporation PODD	768 M	$ 225.21	-0.82 %	$ 15.8 B	USA
Pulmonx Corporation LUNG	23.4 M	$ 1.33	-4.68 %	$ 54.1 M	USA
Quanterix Corporation QTRX	73.9 M	$ 3.68	-6.73 %	$ 157 M	USA
Cutera CUTR	171 M	-	-10.19 %	$ 1.99 M	USA
Dynatronics Corporation DYNT	21.4 M	-	14.99 %	$ 929 K	USA
InspireMD NSPR	6.33 M	$ 1.8	4.05 %	$ 116 M	Israel
Eargo EAR	23 M	-	-	$ 10.2 M	USA